Codexis (CDXS) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free CDXS Stock Alerts $3.29 +0.03 (+0.92%) (As of 01:11 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 3:35 AM | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Given Average Recommendation of "Moderate Buy" by AnalystsCodexis, Inc. (NASDAQ:CDXS - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The averaJune 5, 2024 | americanbankingnews.comCodexis (NASDAQ:CDXS) Now Covered by Analysts at Jefferies Financial GroupJune 3, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Earns Buy Rating from Analysts at Jefferies Financial GroupJefferies Financial Group initiated coverage on shares of Codexis in a report on Monday. They issued a "buy" rating and a $5.00 price target on the stock.May 31, 2024 | americanbankingnews.comCodexis (NASDAQ:CDXS) Coverage Initiated at Cantor FitzgeraldMay 30, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Now Covered by Cantor FitzgeraldCantor Fitzgerald assumed coverage on shares of Codexis in a research note on Thursday. They set an "overweight" rating and a $11.00 target price on the stock.May 22, 2024 | globenewswire.comCodexis to Participate in Jefferies Global Healthcare ConferenceMay 20, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Codexis (CDXS)May 20, 2024 | globenewswire.comCodexis to Participate in TD Cowen 2nd Annual Sustainability WeekMay 15, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Given Consensus Recommendation of "Moderate Buy" by AnalystsCodexis, Inc. (NASDAQ:CDXS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. TheMay 14, 2024 | globenewswire.comCodexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual MeetingMay 4, 2024 | finance.yahoo.comCodexis First Quarter 2024 Earnings: Beats ExpectationsMay 3, 2024 | finance.yahoo.comCodexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...May 3, 2024 | finance.yahoo.comCodexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call TranscriptMay 3, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Given "Buy" Rating at BenchmarkBenchmark reissued a "buy" rating and issued a $9.00 price target on shares of Codexis in a research report on Friday.May 2, 2024 | finance.yahoo.comCodexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic AdvancesMay 1, 2024 | markets.businessinsider.comHere's what to expect from Codexis's earningsMay 1, 2024 | msn.comCodexis Q1 2024 Earnings PreviewApril 26, 2024 | finance.yahoo.comWith 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big gunsApril 19, 2024 | finance.yahoo.comCodexis, Inc. (CDXS)April 18, 2024 | globenewswire.comCodexis to Report First Quarter 2024 Financial Results on May 2April 11, 2024 | marketbeat.comBaillie Gifford & Co. Cuts Stock Position in Codexis, Inc. (NASDAQ:CDXS)Baillie Gifford & Co. cut its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 15.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,419,093 shares of the biotechnology company's stock after selling 630,474 sharApril 11, 2024 | globenewswire.comCodexis Appoints Carole Cobb, MBA, to Strategic Advisory BoardApril 2, 2024 | marketbeat.comAssenagon Asset Management S.A. Sells 296,704 Shares of Codexis, Inc. (NASDAQ:CDXS)Assenagon Asset Management S.A. cut its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 16.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,456,739 shares of the biotechnology company'March 31, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Sees Large Decline in Short InterestCodexis, Inc. (NASDAQ:CDXS - Get Free Report) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 2,290,000 shares, a decrease of 9.8% from the February 29th total of 2,540,000 shares. Based on an average daily trading volume, of 631,800 shares, the days-to-cover ratio is currently 3.6 days.March 30, 2024 | finance.yahoo.comFavourable Signals For Codexis: Numerous Insiders Acquired StockMarch 26, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Codexis, Inc. (NASDAQ:CDXS - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned aMarch 19, 2024 | seekingalpha.comAQST,CDXS and STI are among after hour moversMarch 12, 2024 | marketbeat.comGSA Capital Partners LLP Invests $786,000 in Codexis, Inc. (NASDAQ:CDXS)GSA Capital Partners LLP acquired a new position in Codexis, Inc. (NASDAQ:CDXS - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 416,059 shares of the biotechnology cMarch 8, 2024 | marketbeat.comFmr LLC Boosts Position in Codexis, Inc. (NASDAQ:CDXS)Fmr LLC boosted its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 153.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,335,580 shares of the biotechnology company's stock after acquiring an additional 2,626,400March 2, 2024 | marketbeat.comFederated Hermes Inc. Decreases Stake in Codexis, Inc. (NASDAQ:CDXS)Federated Hermes Inc. lessened its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 44.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,398,031 shares of the biotechnology company's stockMarch 1, 2024 | msn.comBenchmark raises Codexis to buy; cites Q4 earnings, guidanceMarch 1, 2024 | msn.comBenchmark Upgrades Codexis (CDXS)February 29, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Codexis (CDXS)February 29, 2024 | finance.yahoo.comCodexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | finanznachrichten.deCodexis, Inc.: Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsFebruary 29, 2024 | finance.yahoo.comQ4 2023 Codexis Inc Earnings CallFebruary 29, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Raised to "Buy" at BenchmarkBenchmark upgraded shares of Codexis from a "hold" rating to a "buy" rating in a research report on Thursday.February 28, 2024 | benzinga.comRecap: Codexis Q4 EarningsFebruary 28, 2024 | msn.comCodexis GAAP EPS of -$0.10 beats by $0.04, revenue of $26.56M beats by $7.63MFebruary 28, 2024 | finance.yahoo.comCodexis Inc (CDXS) Reports Fiscal Year 2023 Financial ResultsFebruary 28, 2024 | globenewswire.comCodexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsFebruary 28, 2024 | theglobeandmail.comBiotech Rallied Strongly On Exclusive Licensing AgreementFebruary 27, 2024 | marketwatch.comCodexis Shares Up 31% on Roche Licensing AgreementFebruary 27, 2024 | msn.comCodexis Q4 2023 Earnings PreviewFebruary 27, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Position Increased by Acadian Asset Management LLCAcadian Asset Management LLC raised its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 25.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 949,916 shares of the biotechnology company'sFebruary 26, 2024 | msn.comCodexis stock climbs 11% on Roche licensing deal for DNA ligasesFebruary 26, 2024 | globenewswire.comCodexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheFebruary 26, 2024 | globenewswire.comCodexis to Participate in TD Cowen 44th Annual Health Care ConferenceFebruary 20, 2024 | finance.yahoo.comCodexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory BoardFebruary 20, 2024 | globenewswire.comCodexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump convicted... now what? (Ad)Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. But while the Left celebrates his conviction... and the Right rallies around him... the average American is not prepared for what happens next. Which is why it's so important to access this presentation while it's still available online. CDXS Media Mentions By Week CDXS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXS News Sentiment▼0.650.76▲Average Medical News Sentiment CDXS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXS Articles This Week▼22▲CDXS Articles Average Week Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FF News WLKP News REX News OPK News LXRX News VNDA News AGEN News EBS News XOMA News ACHV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored